Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard.
Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows “Accurate diagnosis, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback